On November 18, 2022, Robert Sachs and Clare Love wrote to HHS Secretary Becerra, urging him to act on their patent to use US government rights in three patents on the prostate cancer drug Xtandi. Average Wholesale Price (AWP) price in the USA is $189,800 per year, 3 to 7 times the price is all other high income countries.